Randomized trials
Same-day ART start improves HIV outcomes
Open access · cc by · source: Europe PMC
Rapid ART initiation raised 90-day treatment start and 10-month viral suppression versus standard multi-visit initiation.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Multiple studies in this library examine randomized trials with empirical patient or population outcomes rather than opinion alone.
Evidence for the claim as stated.
Of 463 enrolled, rapid-arm patients initiated ART by 90 days far more often (97% vs 72%) and had higher 10-month suppression (64% vs 51%).
Evidence for the claim as stated.
Effect sizes and settings differ across randomized trials studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Effect sizes and settings differ across randomized trials studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
- Supports · Interdisciplinary frailty RCT
- Supports · Did India’s toilet campaign improve child health?
Study at a glance
- Design
- RCT — RapIT: accelerated same-day ART initiation vs usual stepwise initiation at two public clinics
- N
- N=463 · Rapid vs standard arms with 90-day initiation and 10-month suppression analyses on randomised subsets
- Population
- Adults with HIV at two South African public clinics
- Outcome
- ART initiation by 90 days and viral suppression by 10 months
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
Same-day ART start improves HIV outcomes
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
463 patients were enrolled.
463 provided written informed consent and were enrolled in the study ().
90-day ART initiation was 97% vs 72%.
By 90 d after study enrollment, 97% (182/187) of participants in the rapid arm and 72% (136/190) of participants in the standard arm had initiated ART, equating to a risk difference of 25% (95% CI 19%–33%) and a crude relative risk of 1.36 (1.24–1.49) ().
Key findings
Of 463 enrolled, rapid-arm patients initiated ART by 90 days far more often (97% vs 72%) and had higher 10-month suppression (64% vs 51%).
Methodology
RapIT randomised adults at two public clinics to accelerated first-visit ART initiation versus usual stepwise initiation, then compared ART start by 90 days and viral suppression by 10 months.
Limitations
Unblinded service trial in two clinics may not generalise to all settings; suppression was not universal even in the rapid arm.
Related papers in this topic
Same topic cluster — not a recommendation engine.